Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Nillawan Buathong"'
Autor:
Bertha Wojnarski, Chanthap Lon, Darapiseth Sea, Somethy Sok, Sabaithip Sriwichai, Soklyda Chann, Sohei Hom, Threechada Boonchan, Sokna Ly, Chandara Sok, Samon Nou, Pheaktra Oung, Nareth Kong, Vannak Pheap, Khengheang Thay, Vy Dao, Worachet Kuntawunginn, Mitra Feldman, Panita Gosi, Nillawan Buathong, Mali Ittiverakul, Nichapat Uthaimongkol, Rekol Huy, Michele Spring, Dysoley Lek, Philip Smith, Mark M Fukuda, Mariusz Wojnarski
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0228207 (2020)
BACKGROUND:Primaquine is an approved radical cure treatment for Plasmodium vivax malaria but treatment can result in life-threatening hemolysis if given to a glucose-6-phosphate dehydrogenase deficient (G6PDd) patient. There is a need for reliable po
Externí odkaz:
https://doaj.org/article/ef08d2a9d03b4085b8f7f6c4f4c956af
Autor:
Suwanna Chaorattanakawee, Chanthap Lon, Krisada Jongsakul, Jariyanart Gawee, Somethy Sok, Siratchana Sundrakes, Nareth Kong, Chatchadaporn Thamnurak, Soklyda Chann, Sorayut Chattrakarn, Chantida Praditpol, Nillawan Buathong, Nichapat Uthaimongkol, Philip Smith, Narongrid Sirisopana, Rekol Huy, Satharath Prom, Mark M. Fukuda, Delia Bethell, Douglas S. Walsh, Charlotte Lanteri, David Saunders
Publikováno v:
Malaria Journal, Vol 15, Iss 1, Pp 1-12 (2016)
Abstract Background The recent dramatic decline in dihydroartemisinin-piperaquine (DHA-PPQ) efficacy in northwestern Cambodia has raised concerns about the rapid spread of piperaquine resistance just as DHA-PPQ is being introduced as first-line thera
Externí odkaz:
https://doaj.org/article/4e26b436c9cd4f61b0cdd86ff29d4389
Autor:
Mark M Fukuda, Srivicha Krudsood, Khadeeja Mohamed, Justin A Green, Sukhuma Warrasak, Harald Noedl, Ataya Euswas, Mali Ittiverakul, Nillawan Buathong, Sabaithip Sriwichai, R Scott Miller, Colin Ohrt
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0187376 (2017)
Tafenoquine is an investigational 8-aminoquinoline for the prevention of Plasmodium vivax relapse. Tafenoquine has a long half-life and the potential for more convenient dosing, compared with the currently recommended 14-day primaquine regimen.This r
Externí odkaz:
https://doaj.org/article/875fefbdd0f1461e8a36b71c7a8cc278
Autor:
Chanthap Lon, Jessica E Manning, Pattaraporn Vanachayangkul, Mary So, Darapiseth Sea, Youry Se, Panita Gosi, Charlotte Lanteri, Suwanna Chaorattanakawee, Sabaithip Sriwichai, Soklyda Chann, Worachet Kuntawunginn, Nillawan Buathong, Samon Nou, Douglas S Walsh, Stuart D Tyner, Jonathan J Juliano, Jessica Lin, Michele Spring, Delia Bethell, Jaranit Kaewkungwal, Douglas Tang, Char Meng Chuor, Prom Satharath, David Saunders
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e93138 (2014)
Emerging antimalarial drug resistance in mobile populations remains a significant public health concern. We compared two regimens of dihydroartemisinin-piperaquine in military and civilians on the Thai-Cambodian border to evaluate national treatment
Externí odkaz:
https://doaj.org/article/3a4397fd82884b5f87e273d711c42f01
Autor:
Pattaraporn Vanachayangkul, Darapiseth Sea, Mariusz Wojnarski, Somethy Sok, Chanikarn Kodchakorn, Winita Ta-aksorn, Sohei Hom, Mali Ittiverakul, Worachet Kuntawunginn, Montri Arsanok, Nillawan Buathong, Thay Kheang Heng, Kong Nareth, Samon Nou, Sok Chandara, Sokna Ly, Pheaktra Oung, Brian Vesely, Jason Bennett, Gregory Reichard, Brandon Pybus, Charlotte Lanteri, David Saunders, Mark Fukuda, Philip Smith, Lek Dysoley, Huy Rekol, Norman C. Waters, Michele Spring
Publikováno v:
Antimicrob Agents Chemother
The active metabolites of primaquine, in particular 5-hydroxyprimaquine, likely responsible for the clearance of dormant hypnozoites, are produced through the hepatic CYP450 2D6 (CYP2D6) enzymatic pathway. With the inherent instability of 5-hydroxypr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6c7c4fcc52d519f4e5c02be656dbde4
https://pubmed.ncbi.nlm.nih.gov/34978892
https://pubmed.ncbi.nlm.nih.gov/34978892
Autor:
Kalehiwot M Wubie, Marcus V. G. Lacerda, Françoise Brand, Kim Fletcher, Alemseged Abdissa, Nillawan Buathong, Elizabeth Hardaker, Harald Noedl, Victoria M Rousell, Ermias Diro, Jörg-Peter Kleim, Monica R. F. Costa, Brian Angus, John J Breton, Alejandro Llanos-Cuentas, Lynda Kellam, Reginaldo Z Mia, Marcelo A M Brito, Martin Casapia, Hans-Peter Beck, Fe Espino, Raul Chuquiyauri, Wuelton Marcelo Monteiro, Rezika Mohammed, Donna D Clover, Fernando Val, Sisay Getie, Justin A. Green, Dhelio Batista Pereira, Daniel Yilma, Stephan Duparc, Mauro Shugiro Tada, Cherinet Abebe, Ahmed Zeynudin, Siôn W. Jones, Khadeeja Mohamed, David L. Saunders, Cletus O Ugwuegbulam, Gavin C. K. W. Koh, Chanthap Lon, Srivicha Krudsood
Publikováno v:
The New England Journal of Medicine
Background Treatment of Plasmodium vivax malaria requires the clearing of asexual parasites, but relapse can be prevented only if dormant hypnozoites are cleared from the liver (a treatment termed “radical cure”). Tafenoquine is a single-dose 8-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d64bc83a97e78715cfe8f83b368a046
https://doi.org/10.1056/nejmoa1710775
https://doi.org/10.1056/nejmoa1710775
Autor:
Threechada Boonchan, Panita Gosi, Worachet Kuntawunginn, Soklyda Chann, Samon Nou, Rekol Huy, Dysoley Lek, Sabaithip Sriwichai, Nillawan Buathong, Darapiseth Sea, Vy Dao, Somethy Sok, Bertha Wojnarski, Nichapat Uthaimongkol, Mark M. Fukuda, Chanthap Lon, Pheaktra Oung, Michele D. Spring, Nareth Kong, Khengheang Thay, Sohei Hom, Sokna Ly, Mariusz Wojnarski, Mali Ittiverakul, Mitra Feldman, Philip A. Smith, Vannak Pheap, Chandara Sok
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 1, p e0228207 (2020)
PLoS ONE, Vol 15, Iss 1, p e0228207 (2020)
Background Primaquine is an approved radical cure treatment for Plasmodium vivax malaria but treatment can result in life-threatening hemolysis if given to a glucose-6-phosphate dehydrogenase deficient (G6PDd) patient. There is a need for reliable po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b82c8c823ab924c57b43918dbfcc87e3
https://pubmed.ncbi.nlm.nih.gov/32004348
https://pubmed.ncbi.nlm.nih.gov/32004348
Autor:
Philip A. Smith, Saowaluk Wongarunkochakorn, Soklyda Chann, Jessica T. Lin, Somethy Sok, Vireak Heang, Worachet Kuntawunginn, Michele D. Spring, Satharath Prom, Andrew Vaughn, Suwanna Chaoratanakawee, Hana Burkly, Threechada Boonchan, Thay Keang Heng, Nareth Kong, Mark M. Fukuda, Dysoley Lek, Agus Rachmat, Catherine M. Berjohn, Pattaraporn Vanachayangkul, Nillawan Buathong, Mali Ittiverakul, Chanthap Lon, Mariusz Wojnarski, Dustin Harrison, Panita Gosi, David L. Saunders, Bolin Chum, Andreea Waltmann
Publikováno v:
Open Forum Infect Dis
Background Recent artemisinin-combination therapy failures in Cambodia prompted a search for alternatives. Atovaquone-proguanil (AP), a safe, effective treatment for multidrug-resistant Plasmodium falciparum (P.f.), previously demonstrated additive e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6f2441a85c522485cbca2c86936e04e
Autor:
Nillawan Buathong, Jessica T. Lin, Darapiseth Sea, Philip A. Smith, Shannon Takala-Harrison, Mariusz Wojnarski, Chanthap Lon, Khengheng Thay, Mark M. Fukuda, Nou Samon, Panita Gosi, Michele D. Spring, Rekol Huy, Suwanna Chaorattanakawee, Jaymin C. Patel, David L. Saunders, Soklyda Chann, Lauren Levitz
Gametocytes are the malaria parasite stages responsible for transmission from humans to mosquitoes. Gametocytemia often follows drug treatment, especially as therapies start to fail. We examined Plasmodium falciparum gametocyte carriage and drug resi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e74a19eae2b6d3da5b85ddb7c3f077b
https://europepmc.org/articles/PMC6221238/
https://europepmc.org/articles/PMC6221238/
Autor:
Piyaporn Saingam, Stuart D. Tyner, Christopher V. Plowe, Nillawan Buathong, Shannon Takala-Harrison, Chanthap Lon, David L. Saunders, Jessica T. Lin, Panita Gosi, Kritsanai Yingyuen, Nareth Kong, Youry Se, Satharath Prom, Suwanna Chaorattanakawee, Charlotte A. Lanteri, Worachet Kuntawunginn, Christopher G Jacob, Darapiseth Sea, Siratchana Sundrakes, Paktiya Teja-Isavadharm, Nitima Chanarat, Sabaithip Sriwichai, Thay Kheng Heng, You Yom, Char Meng Chuor, Soklyda Chann, Kuntida Tangthongchaiwiriya
Publikováno v:
Antimicrobial Agents and Chemotherapy. 59:4631-4643
Cambodia's first-line artemisinin combination therapy, dihydroartemisinin-piperaquine (DHA-PPQ), is no longer sufficiently curative against multidrug-resistant Plasmodium falciparum malaria at some Thai-Cambodian border regions. We report recent (200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471fb67e5d062585f0a609c1a39b679c
https://doi.org/10.1128/aac.00366-15
https://doi.org/10.1128/aac.00366-15